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MATERIALS AND METHODS
Chemicals
The following chemicals and solvents were purchased from commercial sources and system. For purification the following reversed phase columns were used: Kromasil 300-10-C4 column (250 × 21.2 mm, 10 μm particle size), Kromasil 300-10-C4 column (250 × 10 mm, 10 μm particle size), Kromasil 300-5-C4 column (250 × 10 mm, 5 μm particle size), Grace Vydac C4 column (250 x 22 mm, 5 μm particle size and a Grace Vydac C4 column (250 x 10 mm, 5 μm particle size). If not indicated otherwise, peptides were dissolved in 6 M Gdn-HCl buffer (pH 4.7) and injected on the reversed phase columns. Elution was achieved by running linear gradients of buffer B (ACN + 0.05 % TFA) in buffer A (ddH2O + 0.05 % TFA). Purified peptides were analyzed by electrospray ionization MS (ESI-MS) operating in positive ion mode. Analytical HPLC analysis of peptides was achieved using a Dionex Ultimate 3000 instrument on a RPKromasil-C4-column (300-5-C4, 150 x 4.6 mm, 5 μm particle size) or Thermo Fisher-C4-column (BioBasic-4, 150 x 4.6, 5 µm particle size) at a flow rate of 1 mL/min with a linear gradient from 5 to 65% buffer B (ACN + 0.08% TFA) in buffer A (ddH2O + 0.1% TFA) over 30 min if not stated otherwise. Detection of peptides was at wavelengths of 214 and 280 nm.
Cloning of recombinant PrP 23-177-MxeIntein-H 6 -CBD.
The plasmid containing this construct was generated from plasmid pTXB3-PrP-23-231-MxeIntein-His 6 -CBD available in our group. 15 It was modified by an inverse PCR approach with the following primers: forward primer 5´-TGCATCACGGGAGATGCAC-3´, reverse primer 5´-GTGCACGAAGTTGTTCTGG-3´. In doing so, 54 triplets coding for amino acids 178-231 were deleted. The resulting PCR product was purified and digested with DpnI (NEB) overnight (o.n.). After purification, the linearized plasmid DNA was phosphorylated at the 5´ end with T4-Polynucleotide-Kinase PNK (NEB) and ligated with T4-Ligase (NEB) at 22°C for 18 h. The ligation mixture was transformed into E. coli XL-1 (Amp R ), grown on an LB-agar-plate (100 µg/mL Ampicillin), colonies were selected and analyzed via colony PCR. Selected clones were sequenced with T7-promotor and T7-terminator primers at Eurofins Genomics AT (Vienna, Austria).
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The results were aligned with the theoretical sequence to confirm in-frame fusion of the inserted PrP genes and MxeIntein. Gdn-HCl (pH 4.7), concentrated and protein α-thioester was purified over RP-HPLC.
Expression and purification of recombinant
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The reaction mixture was loaded on a preparative C4 column (250 x 22 mm, 5 μm particle size, Protein C4, Grace Vydac) that was equilibrated with 5% buffer B (ACN + 0.08% TFA) and 95% buffer A (ddH 2 O + 0.1% TFA). A linear gradient of buffer B from 30-90% (v/v) in 60 min was used to elute the protein α-thioesters from the column.
Elution fractions containing the protein-thioester were combined; pooled and lyophilized. Subsequent identification was done via analytical RP-HPLC, ESI-MS and SDS-PAGE.
Expressed Protein Ligation (EPL) of recombinant PrP 23-177-MESNa thioester with mono-& di-PEGylated or N-acetylated peptides containing N-terminal β-
mercapto-aspartate
All EPL reactions were performed in ligation buffer (6 M Gdn-HCl, 100 mM NaPi buffer and 100 mM MPAA). 50 mM TCEP was used to prevent disulfide formation during EPL. Prior to the ligation, the buffer was degassed with argon for 15 min. Selective desulfurization of β-mercapto-aspartate containing mono-or di-
PEGylated PrP
The peptide (2.5 mM) was added to degassed desulfurization buffer (6 M Gdn-HCl, 200 mM NaPi, 250 mM TCEP, 50 mM DTT, adjusted to pH 2.8-3.0) as a solid. The solution was flushed with argon for 5 min and the reaction vessel was incubated at 65°C for at least 7 h. The reaction was monitored by analytical RP-HPLC and LC-MS.
Upon completion, the reaction mixture was quenched with a four-fold excess of 6 M Gdn-HCl (pH 4.7) and immediately purified by RP-HPLC on a Varian ProStar RP-HPLC System using buffer A and buffer B with a linear gradient of 30-90% B over 60 min.
Product containing collected fractions were pooled, lyophilized and stored at -80°C for further use. S7 fold sample volume), first for 3 h then overnight. The resulting protein solution was centrifuged at 14,000 g at 4°C for 15 min to remove insoluble PrP. Folded protein was analyzed using a NanoDrop 2000 (VWR, Vienna, Austria) to determine concentrations (typically between 0.05-0.2 mg/mL) and CD spectra were collected.
Folding of non-, mono-, di-PEGylated and acetylated PrP variants
Circular Dichroism (CD)
Far UV-CD spectra were measured using a Chirascan Plus spectrometer (Applied Photophysics, UK) between 190-260 nm. Unless stated otherwise, ten spectra with an acquisition time of 10 s for each scan in a 1 mm quartz cell at 1 nm resolution were acquired at r.t. and averaged. Typical protein concentrations were 0.1 mg/mL in folding buffer. To determine the secondary structure, minima at 208 and 222 nm as well as maxima at 193 nm for α-helices were considered, whereas a negative peak at 218 nm and a positive peak at 195 nm were used for the calculation of the percentage of antiparallel β-sheets. The amount of random coil structure was calculated using the maximum peak at 210 nm and minimum peak at 195 nm. All calculations were carried out using CDNN software comparing at least 13 spectra from the database.
Aggregation assays with Thioflavin-T (ThT)
For aggregation assays a procedure modified from Baskakov et al. 
PrP 178(β-mercapto-Asp)-181&197(PEG 27 )-231
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PrP 178(β-mercapto-Asp)-181&197(NHAc)-231
Coupling of Fmoc-NH-(PEG) 27 -OH. 2
Fmoc-NH-(PEG) 27 -OH (2.75 eq.) was dissolved in a solution of 0.5 M HATU in ACN/DMF (40:60 v/v) (2.5 eq. HATU) and 5 eq. DIEA was added. The solution was transferred into the syringe with the peptidyl resin and the syringe was rotated for 20 h. The resin was washed with DMF and subsequently with DCM.
Coupling of Boc-Asp(tBu, STmob)-OH to peptidyl-resin. 3
Boc-Asp(tBu, STmob)-OH (2.0 eq.) was dissolved in a mixture of PyBOP (2.0 eq.), and NMM (4.0 eq.) in DMF (final concentration 0.1 M). The reaction mixture was then added to the resin (1.0 eq.) and rotated at rt for 20 h. Subsequently, the resin was washed with DMF (5 x 3 mL per g resin), DCM (5 × 3 mL per g resin), DMF (5 × 3 mL per g resin), and DCM (10 × 3 mL per g resin).
3.4. Covalent attachment of acetyl groups into Dpr residues of PrP peptides. 4 Mtt temporary protecting groups on Dpr amine side chains were deprotected as described in 3.1. The N-terminus of the peptidyl resin was Boc protected. Acetic anhydride (20% v/v) and DIEA (20% v/v) was added to a mixture of DMF/DCM (1/1). This mixture (10 mL/g resin) was
added to the peptidyl resin and reacted for 1 h. Upon completion, the resin was washed with DMF (3 mL, 1min) and dried in vacuo.
4.
General procedures for recombinant protein expression
Recombinant Expression of wild type, full length PrP.
Wild type (wt), recombinant PrP was generated via hydrolysis of recombinant, full length PrP α-thioester as described previously by Becker and coworkers. 5 The secondary structure was determined using CDNN software via normalization of at least 13 spectra. nm highlighted a tendency for β-sheets, whereas the typical minimum at 218 was not observed, suggesting a predominant random coiled structure ( Figure S10 ). S18
Expressed Protein Ligation (EPL)
Figure
PrP 178(β-mercapto-Asp)-197NHAc-231
Similar results to PrP 178(β-mercapto-Asp)-181NHAc-231 were obtained ( Figure   S11 ). These results suggest that regardless of the position of acetylation, Dpr side chain acetylated C-terminal PrP peptides do not fold into a native full length-like structure. Moreover, compared to the CD spectrum of PrP 23-XPEG 27 -231 (X= aa 181 and/or 197), these peptides showed a higher α-helical content ( Figure S12-14) . 
